The trademark application LUMIIMG was filed by UCB Biopharma SRL, a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). The application was published for oppositions on February 15, 2022, and it was registered by office on May 25, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).